| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Laboratory of Cancer Genetics,*
Institute of
Medical Technology, University of Tampere and Tampere University
Hospital, Tampere, Finland, and the Department of
Oncology,
University Hospital, Lund, Sweden
Amplification at the long arm of chromosome 8 occurs in a large fraction of breast and prostate cancers. To clone the target genes for this amplification, we used suppression subtraction hybridization to identify overexpressed genes in the breast cancer cell line SK-Br-3, which harbors amplification at 8q (8q21 and 8q23-q24). A differentially expressed gene identified by SSH, the p40 subunit of eukaryotic translation initiation factor 3 (eIF3), was localized to 8q23 and found to be highly amplified and overexpressed in the breast and prostate cancer cell lines studied. High-level amplification of eIF3-p40 was found in 30% of hormone-refractory prostate tumors and in 18% of untreated primary breast tumors. In the vast majority of the cases, p40 and c-myc were amplified with equal copy numbers. Tumors with higher copy numbers of p40 than c-myc were also found. Expression of p40 mRNA was analyzed with in situ hybridization. The amplification of eIF3-p40 gene was associated with overexpression of its mRNA, as expected for a functional target gene of the amplification. These results imply that genomic aberrations of translation initiation factors, such as eIF3-p40, may contribute to the pathogenesis of breast and prostate cancer.
This article has been cited by other articles:
 |
|
 |
|
  L. Zhang, Z. Smit-McBride, X. Pan, J. Rheinhardt, and J. W. B. Hershey An Oncogenic Role for the Phosphorylated h-Subunit of Human Translation Initiation Factor eIF3 J. Biol. Chem., August 29, 2008; 283(35): 24047 - 24060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, X. Pan, and J. W. B. Hershey Individual Overexpression of Five Subunits of Human Translation Initiation Factor eIF3 Promotes Malignant Transformation of Immortal Fibroblast Cells J. Biol. Chem., February 23, 2007; 282(8): 5790 - 5800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. LeFebvre, N. L. Korneeva, M. Trutschl, U. Cvek, R. D. Duzan, C. A. Bradley, J. W. B. Hershey, and R. E. Rhoads Translation Initiation Factor eIF4G-1 Binds to eIF3 through the eIF3e Subunit J. Biol. Chem., August 11, 2006; 281(32): 22917 - 22932. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Malta-Vacas, C Aires, P Costa, A R Conde, S Ramos, A P Martins, C Monteiro, and M Brito Differential expression of the eukaryotic release factor 3 (eRF3/GSPT1) according to gastric cancer histological types J. Clin. Pathol., June 1, 2005; 58(6): 621 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Rubin, S. Varambally, R. Beroukhim, S. A. Tomlins, D. R. Rhodes, P. L. Paris, M. D. Hofer, M. Storz-Schweizer, R. Kuefer, J. A. Fletcher, et al. Overexpression, Amplification, and Androgen Regulation of TPD52 in Prostate Cancer Cancer Res., June 1, 2004; 64(11): 3814 - 3822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J M M Tan, E P C Tock, and V T K Chow The novel human MOST-1 (C8orf17) gene exhibits tissue specific expression, maps to chromosome 8q24.2, and is overexpressed/amplified in high grade cancers of the breast and prostate Mol. Pathol., April 1, 2003; 56(2): 109 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Meric and K. K. Hunt Translation Initiation in Cancer: A Novel Target for Therapy Mol. Cancer Ther., September 1, 2002; 1(11): 971 - 979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Tsuchiya, Y. Kondo, A. Takahashi, H. Pawar, J. Qian, K. Sato, M. M. Lieber, and R. B. Jenkins Mapping and Gene Expression Profile of the Minimally Overrepresented 8q24 Region in Prostate Cancer Am. J. Pathol., May 1, 2002; 160(5): 1799 - 1806. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Dunand-Sauthier, C. Walker, C. Wilkinson, C. Gordon, R. Crane, C. Norbury, and T. Humphrey Sum1, a Component of the Fission Yeast eIF3 Translation Initiation Complex, Is Rapidly Relocalized During Environmental Stress and Interacts with Components of the 26S Proteasome Mol. Biol. Cell, May 1, 2002; 13(5): 1626 - 1640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Saramaki, N. Willi, O. Bratt, T. C. Gasser, P. Koivisto, N. N. Nupponen, L. Bubendorf, and T. Visakorpi Amplification of EIF3S3 Gene Is Associated with Advanced Stage in Prostate Cancer Am. J. Pathol., December 1, 2001; 159(6): 2089 - 2094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. HARVEY, Y. ZHANG, F. LANDRY, C. MILLER, and J. W. SMITH Insights into a plasma membrane signature Physiol Genomics, April 2, 2001; 5(3): 129 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rothe, Y. Ko, P. Albers, and N. Wernert Eukaryotic Initiation Factor 3 p110 mRNA Is Overexpressed in Testicular Seminomas Am. J. Pathol., November 1, 2000; 157(5): 1597 - 1604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Lehmann, S. Glockner, W. Kleeberger, H. F. R. von Wasielewski, and H. Kreipe Detection of Gene Amplification in Archival Breast Cancer Specimens by Laser-Assisted Microdissection and Quantitative Real-Time Polymerase Chain Reaction Am. J. Pathol., June 1, 2000; 156(6): 1855 - 1864. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
